 Connection
Spyridon Mastroyannis to Sentinel Lymph Node Biopsy
This is a "connection" page, showing publications Spyridon Mastroyannis has written about Sentinel Lymph Node Biopsy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.401 |
|
|
|
-
Cucinella G, Schivardi G, Zhou XC, AlHilli M, Wallace S, Wohlmuth C, Baiocchi G, Tokgozoglu N, Raspagliesi F, Buda A, Zanagnolo V, Zapardiel I, Jagasia N, Giuntoli R, Glickman A, Peiretti M, Lanner M, Chacon E, Di Guilmi J, Pereira A, Laas-Faron E, Fishman A, Nitschmann CC, Kurnit K, Moriarty K, Joehlin-Price A, Lees B, Covens A, De Brot L, Taskiran C, Bogani G, Landoni F, Grassi T, Paniga C, Multinu F, De Vitis LA, Hern?ndez A, Mastroyannis S, Ghoniem K, Chiantera V, Shahi M, Fought AJ, McGree M, Mariani A, Glaser G. Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study. Int J Gynecol Cancer. 2024 Feb 05; 34(2):179-187.
Score: 0.223
-
Hermann CE, Nasioudis D, Mastroyannis SA, Latif NA, Haggerty AF, Giuntoli Ii RL, Cory L, Kim SH, Morgan MA, Ko EM. Utilization and outcomes of sentinel lymph node biopsy in patients with early stage vulvar cancer. Int J Gynecol Cancer. 2021 01; 31(1):40-44.
Score: 0.179
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|